Civatech Oncology

About:

Civatech Oncology is a medical device company that develops polymer-based devices to treat cancer using localized low-dose-rate radiation.

Website: http://www.civatechoncology.com

Twitter/X: CivaTechOnc

Top Investors: National Institutes of Health

Description:

Civatech Oncology is a medical device company that develops polymer-based devices to treat cancer using localized low-dose-rate radiation. Because polymers are easy to manufacture in different shapes and formats, CivaTech's patented and patent-pending technology enables devices that can be designed and fabricated for specific tumor types. Its first product, the CivaString, has been granted FDA 510k clearance to treat any solid tumor. The company was founded in 2006 and is based in Durham, North Carolina, United States.

Total Funding Amount:

$13.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2006-01-01

Contact Email:

sbabcock(AT)civatechoncology.com

Founders:

Suzanne Troxler Babcock

Number of Employees:

11-50

Last Funding Date:

2023-08-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai